Mira Pharmaceuticals Growth Metrics (2022-2025) | MIRA

Growth Metrics Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 474.83%-52.69%-40.74%-63.23%78.91%279.52%
Assets Growth (3y) (Quarter) 134.70%
Assets (QoQ) (Quarter) 135.76%-45.31%-22.78%-31.49%-52.09%-37.99%779.09%45.33%
Cash & Equivalents Growth (1y) (Quarter) -96.99%3,031.20%1,211.35%259,351.45%-30.13%-38.45%-65.53%-35.57%124.04%
Cash & Equivalents Growth (3y) (Quarter) -4.01%141.56%162.48%
Cash & Equivalents (QoQ) (Quarter) -77.31%87.27%-99.62%1,740.10%23,540.70%-21.57%-23.96%-30.90%-57.42%-39.44%261.62%140.27%
Cash from Operations Growth (1y) (Quarter) -33.94%-6.11%2.40%-30.74%-4.59%-74.40%-52.45%7.40%38.84%34.99%
Cash from Operations Growth (3y) (Quarter) 5.02%-6.35%
Cash from Operations (QoQ) (Quarter) 25.82%-10.24%38.55%-166.53%41.23%-1.40%17.68%-113.22%2.01%11.36%50.00%-40.83%-4.15%
Dividends Paid - Common (QoQ) (Quarter) -142.38%
Enterprise Value Growth (1y) (Quarter) 96.99%-3,031.20%-1,211.35%-259,351.45%30.13%38.45%65.53%-83.80%-289.35%
Enterprise Value Growth (3y) (Quarter) 4.01%-242.59%-215.57%
Enterprise Value (QoQ) (Quarter) 77.31%-87.27%99.62%-1,740.10%-23,540.70%21.57%23.96%30.90%57.42%39.44%-931.64%-46.37%
EPS (Basic) Growth (1y) (Quarter) 47.37%-85.71%-1,433.33%-50.00%-10.00%46.15%62.50%26.67%18.18%-742.86%166.67%
EPS (Basic) Growth (3y) (Quarter) 22.05%-103.51%49.38%
EPS (Basic) (QoQ) (Quarter) 26.32%121.43%-433.33%0.00%-160.00%-53.85%62.50%26.67%-27.27%-7.14%26.67%18.18%-1,211.11%108.47%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) 47.37%-85.71%-1,433.33%-50.00%-10.00%46.15%62.50%26.67%18.18%-742.86%166.67%
EPS (Weighted Average and Diluted) Growth (3y) (Quarter) 22.05%-103.51%49.38%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) 26.32%121.43%-433.33%0.00%-160.00%-53.85%62.50%26.67%-27.27%-7.14%26.67%18.18%-1,211.11%108.47%
FCF Payout Ratio (QoQ) (Quarter) 151.48%
Free Cash Flow Growth (1y) (Quarter) -33.94%-6.11%2.40%-30.74%-4.59%-74.40%-52.45%7.40%38.84%34.99%
Free Cash Flow Growth (3y) (Quarter) 5.02%-6.35%
Free Cash Flow (QoQ) (Quarter) 25.82%-10.24%38.55%-166.53%41.23%-1.40%17.68%-113.22%2.01%11.36%50.00%-40.83%-4.15%
Net Cash Flow Growth (1y) (Quarter) 1,015.10%-873.87%-207.15%-3,102.96%-77.40%-3.62%-48.68%32.45%42.45%379.58%
Net Cash Flow Growth (3y) (Quarter) 70.38%181.98%
Net Cash Flow (QoQ) (Quarter) 125.61%-313.76%106.71%24,793.53%-121.66%15.16%34.36%287.37%-199.31%-21.73%70.18%495.12%94.91%
Net Income towards Common Stockholders Growth (1y) (Quarter) -1,010.37%-149.34%
Net Income towards Common Stockholders (QoQ) (Quarter) -17.41%73.64%
Profit After Tax Growth (1y) (Quarter) 47.75%-98.15%-328.86%-28.09%-33.58%43.03%58.54%-3.84%9.08%44.34%-147.57%
Profit After Tax Growth (3y) (Quarter) 14.06%14.35%-63.89%
Profit After Tax (QoQ) (Quarter) 25.27%25.47%0.63%5.59%-183.37%-61.31%70.32%1.54%-20.84%-17.41%25.67%13.79%26.02%-422.19%
Share-based Compensation Growth (1y) (Quarter) 882.50%44.66%238.44%-17.96%-81.47%155.73%74.89%-13.16%-53.54%686.42%
Share-based Compensation Growth (3y) (Quarter) -5.44%207.56%
Share-based Compensation (QoQ) (Quarter) 0.00%0.00%398.78%96.98%-85.28%133.95%20.91%-55.52%103.26%59.99%-39.97%-76.20%3,340.77%
Shareholder's Equity Growth (1y) (Quarter) 10.46%2,432.48%833.67%276.41%85.44%-55.96%-49.71%-59.00%-74.32%109.86%372.78%
Shareholder's Equity Growth (3y) (Quarter) -19.28%186.04%168.90%
Shareholder's Equity (QoQ) (Quarter) -70.42%-286.06%-200.13%166.87%578.19%-46.10%-27.83%-29.71%61.05%-38.45%-41.17%-55.97%1,216.12%38.67%